---
title: "TNF Pharmaceuticals (TNFA.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/TNFA.US.md"
symbol: "TNFA.US"
name: "TNF Pharmaceuticals"
industry: "Pharmaceuticals"
---

# TNF Pharmaceuticals (TNFA.US)

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |

## Company Profile

TNF Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on developing and commercializing therapeutic platforms based on various therapeutic targets. The company develops Isomyosamine, a clinical stage small molecule that regulates the immunometabolic system to treat autoimmune d...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.87 | 95/257 | - | - | - |
| PB | 1.79 | 85/257 | 1.79 | 1.28 | 0.18 |
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview](https://longbridge.com/en/quote/TNFA.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/TNFA.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/TNFA.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.